Xian Li is a Partner at Kaitai Capital, a venture capital firm founded in 2009 and headquartered in Hangzhou, Zhejiang. See sector focus and contact routes.
Xian Li is a Partner at Kaitai Capital, a venture capital firm founded in 2009 and headquartered in Hangzhou, Zhejiang, China. He previously served as Senior Vice President starting in July 2019 and focuses on biotech and pharmaceutical investments. Kaitai Capital invests across sectors including biopharma, healthcare services, agriculture tech, consumer business, and digital technology, spanning seed to Series C stages. While Li’s specific check size and lead/follow behavior are not publicly documented, his project portfolio includes Rgenta Therapeutics, ABM Therapeutics, Acelink Therapeutics, and Asieris Pharmaceuticals. The firm’s broader investment focus emphasizes biotechnology, precision medicine, medical services, and leisure travel. No distinctive public writing or unique point of view by Li is available in the search results, though his work centers on advancing biotech and pharmaceutical ventures.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Hangzhou.
Investors like Xian Li · Full investor directory · Investor access · Company funding database